Tumor Genomic Profiling
DNA and RNA sequencing to identify cancer biomarkers and guide personalized treatment
Full Insight that Matters
Tumor Genomic Profiling (TGP) analyzes the genetic material of cancer cells to identify mutations, alterations, and biomarkers that drive tumor growth. Utilizing Next-Generation Sequencing (NGS) technologies, TGP provides a comprehensive molecular landscape of a tumor, enabling precision medicine by matching specific genetic alterations with targeted therapies or immunotherapies.
Comprehensive Genomic Profiling (CGP) is the standard approach for advanced and metastatic cancers, analyzing hundreds of genes simultaneously in a single workflow. Unlike single-gene or small-panel tests, CGP detects all four major classes of mutations: single nucleotide variants (SNVs), copy number alterations (CNAs), rearrangements, and insertions/deletions (indels). This breadth allows for the identification of actionable biomarkers such as Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI), which predict response to immunotherapy, and Homologous Recombination Deficiency (HRD), which guides PARP inhibitor use.
Variant Detection
Tumor Genomic Profiling Test Menu
Comprehensive Genomic Profiling (CGP)
CGP is a broad, pan-solid tumor approach that analyzes hundreds of genes simultaneously using next-generation sequencing (NGS).
- Results within 3-5 weeks
- Comprehensive report in one package
- Same coverage as FulGenome
Comprehensive Genomic Profiling (CGP)
CGP is a broad, pan-solid tumor approach that analyzes hundreds of genes simultaneously using next-generation sequencing (NGS).
- Results within 3-5 weeks
- Comprehensive report in one package
- Same coverage as FulGenome
Comprehensive Genomic Profiling (CGP)
CGP is a broad, pan-solid tumor approach that analyzes hundreds of genes simultaneously using next-generation sequencing (NGS).
- Results within 3-5 weeks
- Comprehensive report in one package
- Same coverage as FulGenome
Test Overview
Test Details
Whole genome sequencing (WGS) using next-generation sequencing (NGS) technology to deliver enhanced variant detection, including single nucleotide variants (SNVs), copy number variants (CNVs), genome-wide del/dups, mitochondrial genome alterations, and repeat expansions.
Specimen Requirements
Test Samples
1 x 4ml EDTA Purple Tube
Test Samples
2 x 4ml EDTA Purple Tube
If submitting family member samples, please include them with the proband's sample to avoid delays. Family member samples and information must be received within 3 weeks of the proband's sample receipt to be included in the proband's analysis.
Genomix Reports
Genomix's FulGenome report integrates DNA sequencing, genome-wide del/dups, mitochondrial genome sequencing, and RNA analysis.
How to Order
Collect Sample
Request a kit. Genomix provides specimen collection kits to clinicians.
Complete TRF
Download and fill out the test requisition form (TRF) and submit.
Ship
Send specimen and completed TRF with the provided shipping material.
Receive Report
Results will be available in 3-5 weeks (from lab receipt of sample).